Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

Neurotoxicity of platinum compounds: comparison of the effects of cisplatin and oxaliplatin on the human neuroblastoma cell line SH-SY5Y.

Donzelli E, Carfì M, Miloso M, Strada A, Galbiati S, Bayssas M, Griffon-Etienne G, Cavaletti G, Petruccioli MG, Tredici G.

J Neurooncol. 2004 Mar-Apr;67(1-2):65-73.

PMID:
15072449
2.

Circulating nerve growth factor level changes during oxaliplatin treatment-induced neurotoxicity in the rat.

Cavaletti G, Petruccioli MG, Marmiroli P, Rigolio R, Galbiati S, Zoia C, Ferrarese C, Tagliabue E, Dolci C, Bayssas M, Griffon Etienne G, Tredici G.

Anticancer Res. 2002 Nov-Dec;22(6C):4199-204.

PMID:
12553056
3.

Oxaliplatin loaded PLAGA microspheres: design of specific release profiles.

Lagarce F, Cruaud O, Deuschel C, Bayssas M, Griffon-Etienne G, Benoit J.

Int J Pharm. 2002 Aug 21;242(1-2):243-6.

PMID:
12176255
4.

Anti-Vascular endothelial growth factor treatment augments tumor radiation response under normoxic or hypoxic conditions.

Lee CG, Heijn M, di Tomaso E, Griffon-Etienne G, Ancukiewicz M, Koike C, Park KR, Ferrara N, Jain RK, Suit HD, Boucher Y.

Cancer Res. 2000 Oct 1;60(19):5565-70.

5.

Taxane-induced apoptosis decompresses blood vessels and lowers interstitial fluid pressure in solid tumors: clinical implications.

Griffon-Etienne G, Boucher Y, Brekken C, Suit HD, Jain RK.

Cancer Res. 1999 Aug 1;59(15):3776-82.

6.

Effects of needle insertion in tumors on interstitial fluid pressure.

Griffon-Etienne G, Boucher Y, Jain RK, Suit HD.

Microvasc Res. 1997 Sep;54(2):174-7. No abstract available.

PMID:
9327388
7.

Evaluation of Taxol in head and neck squamous carcinoma multicellular tumor spheroids.

Griffon-Etienne G, Merlin JL, Marchal C.

Anticancer Drugs. 1997 Jan;8(1):48-55.

PMID:
9147611
8.

In vitro evaluation of Taxol combined with radiations in human squamous cell carcinoma spheroids.

Griffon-Etienne G, Merlin JL, Marchal C.

Cancer Lett. 1996 Dec 3;109(1-2):23-32.

PMID:
9020899

Supplemental Content

Loading ...
Support Center